Miralax and Exostosis - a phase IV clinical study of FDA data
Summary:
Exostosis is found among people who take Miralax, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Miralax and have Exostosis. It is created by eHealthMe based on reports of 71,894 people who have side effects when taking Miralax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
71,894 people reported to have side effects when taking Miralax.
Among them, 152 people (0.21%) have Exostosis.
What is Miralax?
Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 72,753 Miralax users for its effectiveness, alternative drugs and more.
What is Exostosis?
Exostosis (formation of new bone on the surface of a bone) is found to be associated with 1,657 drugs and 923 conditions by eHealthMe.
Number of Miralax and Exostosis reports submitted per year:
Time on Miralax when people have Exostosis *:
Gender of people who have Exostosis when taking Miralax*:
Age of people who have Exostosis when taking Miralax *:
Common drugs people take besides Miralax *:
Common side effects people have besides Exostosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Miralax and have Exostosis?
Check whether Exostosis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Exostosis and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Alternative drugs to, pros and cons of Miralax:
- Miralax (72,753 reports)
Common Miralax side effects:
- Drug ineffective: 6,781 reports
- Diarrhea: 5,876 reports
- Fatigue (feeling of tiredness): 4,151 reports
- Constipation: 4,089 reports
- Weakness: 2,977 reports
- Pain: 2,962 reports
- Nausea and vomiting: 2,605 reports
Browse all side effects of Miralax:
a b c d e f g h i j k l m n o p q r s t u v w x y zExostosis treatments and more:
- Exostosis (12,035 reports)
COVID vaccines that are related to Exostosis:
- Exostosis in Moderna COVID Vaccine
- Exostosis in Pfizer BioNTech Covid Vaccine
- Exostosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Exostosis:
- Fosamax: 2,383 reports
- Humira: 1,868 reports
- Zometa: 1,330 reports
- Methotrexate: 1,313 reports
- Prednisone: 1,307 reports
- Enbrel: 1,141 reports
- Aspirin: 959 reports
- Aredia: 807 reports
- Celebrex: 745 reports
- Gabapentin: 694 reports
All the drugs that are associated with Exostosis:
- Exostosis (1,657 drugs)
Common conditions associated with Exostosis:
- Osteoporosis: 2,190 reports
- Rheumatoid arthritis: 2,091 reports
- Pain: 931 reports
- High blood pressure: 833 reports
- Multiple sclerosis: 626 reports
- High blood cholesterol: 610 reports
All the conditions that are associated with Exostosis:
- Exostosis (923 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chronic Obstructive Pulmonary Disease and Granuloma Annulare - 7 seconds ago
- Ambien Cr and Periorbital Haematoma - 10 seconds ago
- Locoid and Breathing Difficulty - 12 seconds ago
- Capecitabine and Actigall drug interaction - 13 seconds ago
- Omeprazole and Demyelinating Polyneuropathy - 15 seconds ago
- Tri-Sprintec and Nosebleed - 18 seconds ago
- Enoxaparin Sodium and Enterocolitis Infectious - 24 seconds ago
- Xarelto and Victoza drug interaction - 46 seconds ago
- Mycophenolate Mofetil and Bumetanide drug interaction - 47 seconds ago
- Abacavir and Maraviroc drug interaction - 50 seconds ago